APA

Rascol O., Arnulf I., Peyro-Saint Paul H., Brefel-Courbon C., Vidailhet M., Thalamas C., Bonnet A. M., Descombes S., Bejjani B., Fabre N., Montastruc J. L. & Agid Y. (20011018). Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

Chicago

Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet A M, Descombes S, Bejjani B, Fabre N, Montastruc J L and Agid Y. 20011018. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

Harvard

Rascol O., Arnulf I., Peyro-Saint Paul H., Brefel-Courbon C., Vidailhet M., Thalamas C., Bonnet A. M., Descombes S., Bejjani B., Fabre N., Montastruc J. L. and Agid Y. (20011018). Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society.

MLA

Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet A M, Descombes S, Bejjani B, Fabre N, Montastruc J L and Agid Y. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. : Movement disorders : official journal of the Movement Disorder Society. 20011018.